Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
70 studies found for:    E-selectin
Show Display Options
Rank Status Study
1 Terminated E-Selectin Nasal Spray to Prevent Stroke Recurrence
Conditions: Cerebrovascular Accident;   Transient Ischemic Attack
Intervention: Drug: E-Selectin nasal spray
2 Not yet recruiting E-Selectin Nasal Instillation to Prevent Secondary Stroke
Conditions: Ischemic Attack, Transient;   Transient
Intervention: Drug: Intransal instillation of E-selectin
3 Completed
Has Results
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: sunitinib
4 Completed A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
Condition: Atherosclerosis
Interventions: Drug: Olmesartan medoxomil;   Drug: Placebo
5 Completed
Has Results
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Methotrexate;   Drug: Placebo
6 Completed
Has Results
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
7 Suspended Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
Condition: Melanoma
Interventions: Biological: MELITAC 12.1;   Drug: Imiquimod
8 Completed
Has Results
Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin and Pioglitazone;   Drug: Alogliptin;   Drug: Placebo
9 Completed
Has Results
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
Conditions: Diabetes Mellitus;   Dyslipidemias
Interventions: Drug: Pioglitazone and Metformin;   Drug: Glimepiride and Metformin
10 Completed
Has Results
Periodontal Infection and Endothelial Dysfunction
Condition: Periodontitis
Interventions: Procedure: One-Stage Full-Mouth Disinfection;   Procedure: Periodontal care
11 Completed
Has Results
Abatacept With Methotrexate- Phase IIB
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept (BMS-188667);   Drug: Placebo
12 Completed
Has Results
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
Conditions: Heart Transplantation;   Heart Diseases
Interventions: Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: Mycophenolate mofetil;   Drug: Methylprednisolone;   Drug: Prednisone
13 Terminated GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: GI-270384
14 Completed The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery
Conditions: Myocardial Reperfusion Injury;   Cytoprotection
Intervention: Drug: Hyperbaric Oxygen
15 Completed Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: Low dose of BIBT 986 CL,  per i.v. infusion;   Drug: Medium dose of BIBT 986 CL, per i.v. infusion;   Drug: High dose of BIBT 986 CL, per i.v. infusion;   Drug: Placebo;   Drug: Lipopolysaccharide (LPS), single i.v. bolus
16 Recruiting Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV
Conditions: HIV;   Acquired Immunodeficiency Syndrome;   Cardiovascular Diseases
Interventions: Behavioral: Exercise Program;   Behavioral: Control Group
17 Unknown  Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
Condition: Diabetes Mellitus Type II
Interventions: Drug: Metformin;   Drug: Vildagliptin;   Drug: Glimepiride
18 Completed Metabolic Consequences of Moderate Weight Gain - Role of Dietary Fat Composition (LIPOGAIN)
Condition: Healthy
Interventions: Other: Polyunsaturated fatty acid group;   Other: Saturated fatty acid group
19 Completed Effects of n-3 Polyunsaturated Fatty Acids and Antioxidants on Postprandial Hyperlipidemia and Vascular Function in Men
Conditions: Cardiovascular Diseases;   Vasodilation
Intervention: Behavioral: Nutrition
20 Recruiting Tenofovir Abacavir Platelet Activation Study
Condition: HIV
Interventions: Drug: abacavir (600 mg QD);   Drug: tenofovir (245 mg QD)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years